Pharmacology Flashcards

1
Q

What is pharmacology?

A

A branch of science that deals with the study of drugs and their actions on living systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a drug?

A

A chemical with a selective therapeutic action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Pharmacodynamics (PD)?

A

What the drug does to the body.
Drug action and mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Pharmacokinetics (PK)?

A

What the body does to the drug.
Barriers (ADME).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is biological specificity?

A

Right target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is chemical specificity?

A

Right target binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does the B1 receptor do?

A

Increases heart rate; Increasing cardiac muscle’s force of contraption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the B2 receptor do?

A

Relaxes the airway.
Dilatate smooth muscles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do target binding sites provide?

A

The selectivity for the specific binding of drugs/ligands (LOCK and KEY system).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 key drug binding sites?

A
  1. Drugs targeting enzymes.
  2. Drugs targeting transporters.
  3. Drug targeting voltage-gated ion channels.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs as enzyme inhibitors.

A

Intracellular breakdown - phosphodiesterase- sildenafil.
Neurotransmitter degradation - acetylcholine esterase - neostigmine.
Messenger synthesis - cyclo-oxygenase - ibuprofen (reversable) aspirin (irreversible).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs as enzyme substrates

A

dopamine precursor L-DOPA for Parkinson’s disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is meant by competitive binding?

A

Drug competes for the ligand active site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is meant by non-competitive binding?

A

Drug binds at different site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapeutic action

A

Biological: right target.
Chemical: right target binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse/Side effects

A

Biological: non-specific target.
Chemical: non-specific binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is an agonist?

A

A drug that binds to the same active site as adrenaline and activates the B2 like adrenaline.

18
Q

What is an antagonist?

A

Drugs that oppose the agonist function.
Block the B1 receptor.

19
Q

What is Affinity?

A

How well a drug/ligand binds to it’s receptor.

20
Q

What is Efficacy?

A

How well a drug/ligand activates the receptor.

21
Q

Do agonists have affinity and efficacy?

A

Agonists have both affinity and efficacy.

22
Q

Do antagonists have affinity and efficacy?

A

Antagonists only have affinity.
THEY PRODUCE NO RESPONSE.

23
Q

What is kD?

A

The concentration req. to occupy 50% of receptor.

24
Q

What is EC50?

A

The effective concentration of agonist for 50% response.

25
Which is usually higher, affinity(kD) or potency(EC50)?
Affinity (kD).
26
What is antagonism?
Drug/ligand that reduces/blocks the agonist response
27
Name a type of antagonism?
Receptor antagonism
28
Why do antagonists only have affinity?
Binds to receptors, Null response, i.e. blocks agonist response.
29
Competitive antagonism.
Orthosteric - same binding site of the endogenous hormone. Block the drug by occupying the B1 binding site.
30
Non-competitive antagonism.
Blocks the response by by binding at a different binding site to the agonist. No need for them to have identical structures.
31
Reversable and non-reversable
Reversable can dissociate from the receptor and binding sites can be re-occupied. Non-reversable antagonists cannot dissociate from the receptor.
32
Reversable competitive antagonists
Max. response can still be achieved (surmountable antagonism).
33
Irreversible competitive antagonists.
Form covalent link with receptor. Reduces the number of receptors available for the agonist to stimulate the response.
34
Non-surmountable antagonism
EC50 declines as receptor reserves decrease. agonists maximum response drops.
35
Receptor Tyrosine Kinase (RTK)
Receptors for growth factors (EGF, VEGF, Insulin etc.). Activation: Cell proliferation, differentiation, survival and metabolism. Hyperactivation: Polyps, tumours and cancer.
36
Receptors for growth factors EGF, VEGF, IGF, PDGF
Epidermal growth factor. Vascular endothelial growth factor. Insulin-like growth factor. Platelet-derived growth factor
37
RTK
Growth factor binding RTK leads dimerization and autophosphorylation
38
RTK
One tyrosine kinase activates autophosphorylation of its partner and vice versa. signalling proteins recruited to RTK. Signalling proteins contains SH2 domain to sense and bind specific RTK.
39
SH2 domain
some SH2 proteins are enzymes (phospholipase C) Some SH2 domain proteins are adaptors (Grb2).
40
RTK - drugs
Very limited Insulin Many neurotrophin analogues couldn't pass through clinical trials. Monoclonal antibodies.
41
Guanynyl cyclase receptors
Limited membrane bound released from atria, promotes vasodilation and urinary sodium excretion.